Comparison of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat model

Stem Cell Research and Therapy

Volumn 5, Issue 2, 2014, Pages

  Chung, Jun Young ^a   Song, Minjung ^a   Ha, Chul Won ^a   Kim, Jin A ^a   Lee, Choong Hee ^a   Park, Yong Beom ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CHITOSAN; COLLAGEN TYPE 2; HYALURONIC ACID; POLOXAMER; HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE INJURY; CELL DEGENERATION; COMPOSITE GRAFT; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MASSON TRICHROME STAINING; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; SAFRANIN O STAINING; SIRIUS RED STAINING; STAINING; TISSUE REGENERATION; TISSUE REPAIR; UMBILICAL CORD BLOOD; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; DISEASE MODEL; FETUS BLOOD; MESENCHYMAL STROMA CELL; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; WOUND HEALING;

ANIMALS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL BLOOD; HUMANS; HYDROGEL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; WOUND HEALING;

EID: 84898438539     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt427     Document Type: Article

References (58)

1. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. Im GI, Kim DY, Shin JH, Hyun CW, Cho WH, J Bone Joint Surg Br 2001 83 289 294 10.1302/0301-620X.83B2.10495 11284583
2. Comparing the chondrogenic potential in vivo of autogeneic mesenchymal stem cells derived from different tissues. Li Q, Tang J, Wang R, Bei C, Xin L, Zeng Y, Tang X, Artif Cells Blood Substit Immobil Biotechnol 2011 39 31 38 10.3109/10731191003776769 21117872
3. Mesenchymal stem cells for clinical application. Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R, Vox Sang 2010 98 93 107 10.1111/j.1423-0410.2009.01227.x 19663934
4. Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage. Steck E, Fischer J, Lorenz H, Gotterbarm T, Jung M, Richter W, Stem Cells Dev 2009 18 969 978 10.1089/scd.2008.0213 19049404
5. UC blood-derived mesenchymal stromal cells: an overview. Flynn A, Barry F, O'Brien T, Cytotherapy 2007 9 717 726 10.1080/14653240701584578 17917891 (Pubitemid 350226750)
6. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. Kim JY, World J Stem Cells 2010 2 34 10.4252/wjsc.v2.i2.34 21607114
7. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Lee HJ, Lee JK, Lee H, Shin JW, Carter JE, Sakamoto T, Jin HK, Bae JS, Neurosci Lett 2010 481 30 35 10.1016/j.neulet.2010.06.045 20600610
8. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Chang SA, Lee EJ, Kang HJ, Zhang SY, Kim JH, Li L, Youn SW, Lee CS, Kim KH, Won JY, Sohn JW, Park KW, Cho HJ, Yang SE, Oh WI, Yang YS, Ho WK, Park YB, Kim HS, Stem Cells 2008 26 1901 1912 10.1634/stemcells.2007-0708 18403756
9. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. Chung DJ, Choi CB, Lee SH, Kang EH, Lee JH, Hwang SH, Han H, Choe BY, Lee SY, Kim HY, J Neurosci Res 2009 87 3554 3567 10.1002/jnr.22162 19642203
10. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, Kang S, Jin HJ, Yang YS, Park WS, Cell Transplant 2009 18 869 886 10.3727/096368909X471189 19500472
11. Hydrogels in regenerative medicine. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA, Adv Mater 2009 21 3307 3329 10.1002/adma.200802106 20882499
12. Hydrogels for biomedical applications. Hoffman AS, Adv Drug Deliv Rev 2002 54 3 12 10.1016/S0169-409X(01)00239-3 11755703 (Pubitemid 34081178)
13. Thermosensitive chitosan-Pluronic hydrogel as an injectable cell delivery carrier for cartilage regeneration. Park KM, Lee SY, Joung YK, Na JS, Lee MC, Park KD, Acta Biomater 2009 5 1956 1965 10.1016/j.actbio.2009.01.040 19261553
14. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Goa KL, Benfield P, Drugs 1994 47 536 566 10.2165/00003495-199447030- 00009 7514978
15. Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Chung C, Burdick JA, Tissue Eng Part A 2009 15 243 254 19193129
16. Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels. Chung C, Erickson IE, Mauck RL, Burdick JA, Tissue Eng Part A 2008 14 1121 1131 10.1089/ten.tea.2007.0291 18407752 (Pubitemid 351931507)
17. Influence of gel properties on neocartilage formation by auricular chondrocytes photoencapsulated in hyaluronic acid networks. Chung C, Mesa J, Randolph MA, Yaremchuk M, Burdick JA, J Biomed Mater Res A 2006 77 518 525 16482551 (Pubitemid 47233576)
18. Differential maturation and structure-function relationships in mesenchymal stem cell- and chondrocyte-seeded hydrogels. Erickson IE, Huang AH, Chung C, Li RT, Burdick JA, Mauck RL, Tissue Eng Part A 2009 15 1041 1052 10.1089/ten.tea.2008.0099 19119920
19. The use of debrided human articular cartilage for autologous chondrocyte implantation: maintenance of chondrocyte differentiation and proliferation in type I collagen gels. Chaipinyo K, Oakes BW, Van Damme MP, J Orthop Res 2004 22 446 455 10.1016/j.orthres.2003.07.001 15013108 (Pubitemid 38155304)
20. Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Ibusuki S, Fujii Y, Iwamoto Y, Matsuda T, Tissue Eng 2003 9 371 384 10.1089/107632703764664846 12740100 (Pubitemid 36944187)
21. Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gel. Uchio Y, Ochi M, Matsusaki M, Kurioka H, Katsube K, J Biomed Mater Res 2000 50 138 143 10.1002/(SICI)1097-4636(200005)50:2<138::AID- JBM7>3.0.CO;2-K 10679677 (Pubitemid 30126957)
22. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H, Choi S, Oh W, Yang YS, Cytotherapy 2004 6 476 486 10.1080/14653240410005041 15512914 (Pubitemid 39433582)
23. Neochondrogenesis in repair of full-thickness articular cartilage defects using free autogenous periosteal grafts in the rabbit. A follow-up in six months. Carranza-Bencano A, Garcia-Paino L, Armas Padron JR, Cayuela Dominguez A, Osteoarthritis Cartilage 2000 8 351 358 10.1053/joca.1999.0309 10966841
24. Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. O'Driscoll SW, Keeley FW, Salter RB, J Bone Joint Surg Am 1988 70 595 606 3356727
25. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L, N Engl J Med 1994 331 889 895 10.1056/ NEJM199410063311401 8078550 (Pubitemid 24299869)
26. Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Brittberg M, Nilsson A, Lindahl A, Ohlsson C, Peterson L, Clin Orthop Relat Res 1996 326 270 283 8620653 (Pubitemid 26147776)
27. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. Grande DA, Pitman MI, Peterson L, Menche D, Klein M, J Orthop Res 1989 7 208 218 10.1002/jor. 1100070208 2918421 (Pubitemid 19071033)
28. Bone marrow mesenchymal stem cells in a hyaluronan scaffold for treatment of an osteochondral defect in a rabbit model. Løken S, Jakobsen RB, Årøen A, Heir S, Shahdadfar A, Brinchmann JE, Engebretsen L, Reinholt FP, Knee Surg Sports Traumatol Arthrosc 2008 16 896 903 10.1007/s00167-008-0566-2 18592218
29. Cartilage regeneration using adipose-derived stem cells. Ogawa R, Mizuno S, Curr Stem Cell Res Ther 2010 5 129 132 10.2174/157488810791268627 19941456
30. Repair of articular cartilage defect in non-weight bearing areas using adipose derived stem cells loaded polyglycolic acid mesh. Cui L, Wu Y, Cen L, Zhou H, Yin S, Liu G, Liu W, Cao Y, Biomaterials 2009 30 2683 2693 10.1016/j.biomaterials.2009.01.045 19217157
31. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. Shao X, Goh JC, Hutmacher DW, Lee EH, Zigang G, Tissue Eng 2006 12 1539 1551 10.1089/ten.2006.12.1539 16846350 (Pubitemid 44174788)
32. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Liu Y, Shu XZ, Prestwich GD, Tissue Eng 2006 12 3405 3416 10.1089/ten.2006.12.3405 17518677 (Pubitemid 46037164)
33. Autologous chondrocyte implantation with collagen bioscaffold for the treatment of osteochondral defects in rabbits. Willers C, Chen J, Wood D, Xu J, Zheng MH, Tissue Eng 2005 11 1065 1076 10.1089/ten.2005.11.1065 16144442 (Pubitemid 41321409)
34. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Oh W, Kim D, Yang Y, Lee J, Cell Immunol 2008 251 116 123 10.1016/j.cellimm.2008.04.003 18495100
35. Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells. Gao J, Dennis JE, Solchaga LA, Awadallah AS, Goldberg VM, Caplan AI, Tissue Eng 2001 7 363 371 10.1089/10763270152436427 11506726 (Pubitemid 32737203)
36. Healing full-thickness cartilage defects using adipose-derived stem cells. Dragoo JL, Carlson G, McCormick F, Khan-Farooqi H, Zhu M, Zuk PA, Benhaim P, Tissue Eng 2007 13 1615 1621 10.1089/ten.2006.0249 17518742 (Pubitemid 47105768)
37. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B, Stem Cells 2007 25 750 760 17095706 (Pubitemid 46354235)
38. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T, Arthritis Rheum 2005 52 2521 2529 10.1002/art.21212 16052568 (Pubitemid 41117441)
39. Chondrogenic differentiation of human umbilical cord blood-derived multilineage progenitor cells in atelocollagen. Choi Y, Im M, Kim C, Lee M, Noh S, Lim S, Kim S, Cho C, Kim D, Cytotherapy 2008 10 165 173 10.1080/ 14653240701817002 18368595
40. How chondrogenic are human umbilical cord matrix cells? A comparison to adipose-derived stem cells. Hildner F, Wolbank S, Redl H, van Griensven M, Peterbauer A, J Tissue Eng Regen Med 2010 4 242 245 10.1002/term.236 19998317
41. Chondrogenic differentiation of human mesenchymal stem cells from umbilical cord blood in chemically synthesized thermoreversible polymer. Kao IT, Yao CL, Chang YJ, Hsieh TB, Hwang SM, Chin J Physiol 2008 51 252 258 19112883
42. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S, Cell Transplant 2004 13 595 600 10.3727/000000004783983747 15565871 (Pubitemid 39557438)
43. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M, Osteoarthritis Cartilage 2002 10 199 206 10.1053/joca.2001.0504 11869080 (Pubitemid 34189569)
44. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM, J Bone Joint Surg Am 1994 76 579 592 8150826 (Pubitemid 24154130)
45. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Djouad F, Bouffi C, Ghannam S, Noel D, Jorgensen C, Nat Rev Rheumatol 2009 5 392 399 10.1038/nrrheum.2009.104 19568253
46. Mesenchymal stem cells as trophic mediators. Caplan AI, Dennis JE, J Cell Biochem 2006 98 1076 1084 10.1002/jcb.20886 16619257 (Pubitemid 44128350)
47. In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation. Yang SH, Wu CC, Shih TT, Sun YH, Lin FH, Spine (Phila Pa 1976) 2008 33 1951 1957 10.1097/BRS. 0b013e31817e6974 18708927
48. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Fischer J, Dickhut A, Rickert M, Richter W, Arthritis Rheum 2010 62 2696 2706 10.1002/art.27565 20496422
49. Micromass co-culture of human articular chondrocytes and human bone marrow mesenchymal stem cells to investigate stable neocartilage tissue formation in vitro. Giovannini S, Diaz-Romero J, Aigner T, Heini P, Mainil-Varlet P, Nesic D, Eur Cell Mater 2010 20 245 259 20925023
50. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Chang JW, Hung SP, Wu HH, Wu WM, Yang AH, Tsai HL, Yang LY, Lee OK, Cell Transplant 2011 20 245 257 10.3727/096368910X520056 20719085
51. Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro. Hao L, Zhang C, Chen XH, Zou ZM, Zhang X, Kong PY, Liang X, Gao L, Peng XG, Sun AH, Wang QY, Croat Med J 2009 50 351 360 10.3325/cmj.2009.50.351 19673035
52. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, Xu J, Immunology 2009 126 220 232 10.1111/j.1365-2567.2008.02891.x 18624725
53. Mesenchymal stem cells: mechanisms of inflammation. Singer NG, Caplan AI, Annu Rev Pathol 2011 6 457 478 10.1146/annurev-pathol-011110-130230 21073342
54. In situ cross-linkable hyaluronan hydrogel enhances chondrogenesis. Aulin C, Bergman K, Jensen-Waern M, Hedenqvist P, Hilborn J, Engstrand T, J Tissue Eng Regen Med 2011 5 188 e196 10.1002/term.415 21394931
55. Studies on in situ hydrogel: a smart way for safe and sustained ocular drug delivery. Shastri D, Patel L, Parikh R, J Young Pharm 2010 2 116 120 10.4103/0975-1483.63144 21264112
56. In vivo study of a blended hydrogel composed of pluronic F-127-alginate-hyaluronic acid for its cell injection application. Haider SI, Choi JY, Lee JS, Lim HJ, Lee C, Kim J, Chung HY, Jeong OK, Tissue Eng Regen Med 2012 9 1 9 10.1007/s13770-012-0001-0
57. Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering. Mouw JK, Case ND, Guldberg RE, Plaas AH, Levenston ME, Osteoarthritis Cartilage 2005 13 828 836 10.1016/j.joca.2005.04. 020 16006153 (Pubitemid 41263941)
58. The composition of hydrogels for cartilage tissue engineering can influence glycosaminoglycan profile. Wang QG, Hughes N, Cartmell SH, Kuiper NJ, Eur Cell Mater 2010 19 86 95 20186668